<?xml version='1.0' encoding='utf-8'?>
<document id="19267776"><sentence text="Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid."><entity charOffset="53-66" id="DDI-PubMed.19267776.s1.e0" text="acenocoumarol" /><entity charOffset="71-82" id="DDI-PubMed.19267776.s1.e1" text="amoxicillin" /><entity charOffset="88-103" id="DDI-PubMed.19267776.s1.e2" text="clavulanic acid" /><pair ddi="false" e1="DDI-PubMed.19267776.s1.e0" e2="DDI-PubMed.19267776.s1.e0" /><pair ddi="false" e1="DDI-PubMed.19267776.s1.e0" e2="DDI-PubMed.19267776.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19267776.s1.e0" e2="DDI-PubMed.19267776.s1.e2" /><pair ddi="false" e1="DDI-PubMed.19267776.s1.e1" e2="DDI-PubMed.19267776.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19267776.s1.e1" e2="DDI-PubMed.19267776.s1.e2" /></sentence><sentence text="A pharmacokinetic-pharmacodynamic (PK-PD) drug-drug interaction between acenocoumarol and amoxicillin + clavulanic acid antibiotic was assessed in eight healthy volunteers, using a population PK-PD) model"><entity charOffset="72-85" id="DDI-PubMed.19267776.s2.e0" text="acenocoumarol" /></sentence><sentence text=" Each subject received at day 1 a single dose of 8 mg of acenocoumarol"><entity charOffset="57-70" id="DDI-PubMed.19267776.s3.e0" text="acenocoumarol" /></sentence><sentence text=" Then 1 g of amoxicillin + 250 mg of clavulanic acid was given from days 3 to 9"><entity charOffset="13-24" id="DDI-PubMed.19267776.s4.e0" text="amoxicillin" /><entity charOffset="37-52" id="DDI-PubMed.19267776.s4.e1" text="clavulanic acid" /><pair ddi="false" e1="DDI-PubMed.19267776.s4.e0" e2="DDI-PubMed.19267776.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19267776.s4.e0" e2="DDI-PubMed.19267776.s4.e1" /></sentence><sentence text=" On day 8, each subject received a single dose of 8 mg of acenocoumarol concomitantly with the antibiotic combination"><entity charOffset="58-71" id="DDI-PubMed.19267776.s5.e0" text="acenocoumarol" /></sentence><sentence text=" Eleven blood samples were taken during 48 h following each acenocoumarol administration"><entity charOffset="60-73" id="DDI-PubMed.19267776.s6.e0" text="acenocoumarol" /></sentence><sentence text=" Acenocoumarol plasma concentrations and prothrombin time were measured at each sampling time"><entity charOffset="1-14" id="DDI-PubMed.19267776.s7.e0" text="Acenocoumarol" /></sentence><sentence text=" We first identified the structural PK model by pooling data from this trial with individual data from other acenocoumarol PK trials"><entity charOffset="109-122" id="DDI-PubMed.19267776.s8.e0" text="acenocoumarol" /></sentence><sentence text=" An indirect response model was used to fit PD data" /><sentence text=" Models were built using a non-linear mixed effect modelling approach with nonmem software" /><sentence text=" Covariates were tested on PK and PD parameters, including antibiotic treatment" /><sentence text=" Acenocoumarol PK data were fitted by a two-compartment, first-order input model with log normal inter-individual variability" /><sentence text=" Weight and antibiotic treatment were found to improve significantly the fit of PK data with a 15% decrease in acenocoumarol clearance with concomitant antibiotics (P &lt; 0"><entity charOffset="111-124" id="DDI-PubMed.19267776.s13.e0" text="acenocoumarol" /></sentence><sentence text="05)" /><sentence text=" An indirect response model was successfully applied to the PK-PD data of acenocoumarol"><entity charOffset="74-87" id="DDI-PubMed.19267776.s15.e0" text="acenocoumarol" /></sentence><sentence text=" No covariate, including antibiotic treatment effect, significantly affected PT" /><sentence text=" Drug-drug interaction was demonstrated at the PK level, without any PD corollary" /><sentence text="" /></document>